Indiana University School of Medicine - Wells Center for Pediatric Research
Indianapolis, Indiana, 46202, United States
NCT Number: NCT05322785
This is an exploratory study designed to optimize, standardize, and validate novel breath biomarkers; there are no objective endpoints. The goal of this study is to generate pilot data to be used to generate hypothesis-driven studies.
Interested in participating?
Request Info4 year–110 year
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46202, United States
Exhaled breath has three fractions - gaseous breath, volatile breath, and breath condensate. Biomarkers have been identified in each of these fractions and non-invasive collection methods have been developed. Exhaled breath can be safely and easily performed in all patient populations, including neonatal children and the elderly. We have shown that relative to normal controls, condensed exhalates obtained from asthmatic subjects reproducibly contain elevated concentrations of oxides of nitrogen and are more acidic (having hydrogen ion concentrations two to three log orders higher). We wish to extend these studies across all breath fractions and other lung diseases and respiratory processes including viral upper respiratory tract infections, cystic fibrosis, pneumonia, pulmonary hypertension, bronchiolitis obliterans, chronic obstructive pulmonary disease, tracheostomized patients and cigarette smokers. Through this study extension, we will obtain pilot data/preliminary information about the potential utility of this new technique to non-invasively evaluate disease status in various respiratory diseases. We also wish to obtain data regarding specificity by evaluating the exhaled breath obtained from patients with non-respiratory illnesses, such as, but not limited to diabetes, gastroenteritis, and various inflammatory disorders. We think it is likely that the exhaled biomarkers reflect underlying airway inflammation and infection.
Following informed consent, exhaled breath will be passively collected from subjects during quiet oral breathing through a simple mouthpiece or mask. Exhaled breath will be diverted into a collection device, which may include a bag, tube, or other device with minimal resistance. The collection process, including completing forms, will not exceed 30 minutes.
Subjects may be asked to provide several specimens during the course of their inpatient stay or clinic visit to obtain longitudinal data.
At no time will the patients be breathing anything other than ambient air with or without oxygen enrichment as clinically indicated. Inhaled air will not be manipulated.
Exhaled breath collection technique is completely comfortable, causing neither discomfort nor fatigue.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exhaled breath will be passively collected from subjects during quiet oral breathing through a simple mouthpiece or mask
Time frame: During the exhaled breath collection procedure, not to exceed 30 minutes
Breath collected will be measured for total volume of condensation collected, pH from the pH scale and other components of airway factors
Indiana University
Other
Acronym: EBC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03319446
Digestive System Diseases, Gastrointestinal Disease
Salt Lake City, Utah, United States
View Trial DetailsNCT06716502
Healthy, Respiration Disorders
Lecce, Apulia, Italy
View Trial DetailsNCT05962645
COPD, Chronic Disease
Miami, Florida, United States
View Trial DetailsNCT06271213
Asthma in Children, Digestive System Diseases
Glasgow, United Kingdom
View Trial Details